Induction of Myocarditis Lesions in Lewis Rats by Formalin-Killed Cells of Group a Streptococcus

Abstract

The feasibility of inducing rheumatic myocarditis lesions in Lewis rats by immunization with formalin-killed group A Streptococcus was evaluated. The rats were divided into three groups. Group A was immunized by injecting formalin-killed group A Streptococcus suspended in complete Freund's adjuvant (CFA) into the hind-foot pads and repeat immunization was given 1 week later by subcutaneous injection into the belly. The rats were then sacrificed 3 weeks after the initial immunization. In group B, the rats received the same initial immunization as group A, but the repeat immunization was carried out at 1, 2 and 3 weeks after the initial immunization and the rats were sacrificed 6 weeks after the initial immunization. Group C was a control group with the rats injected with saline/CFA and sacrificed on the same schedule as group A. Heart pathology sections showed that myocarditis lesions, focal inflammatory cell infiltration in interstitial near small vessels and valvulitis were induced in Lewis rats following immunization with formalin-killed group A Streptococcus.

Keywords

Streptococcus pyogenes Rat disease model Rheumatic Myocarditis Focal inflammatory cell infiltration Valvulitis

References

Carapetis

McDonald

Wilson

: Acute rheumatic fever. Lancet 2005; 366: 155–168.

World Health Organization Expert Consultation: Rheumatic fever and rheumatic heart disease. World Health Organ Tech Rep Ser 2004; 923: 1–122.

Quinn

Kosanke

Fischetti

: Induction of autoimmune valvular heart disease by recombinant streptococcal M protein. Infect Immun 2001; 69: 4072–4078.

Fukuizumi

Inoue

Tsujisawa

: Streptococcus sobrinus antigens that react to salivary antibodies induced by tonsillar application of formalin-killed S. sobrinus in rabbits. Infect Immun 2000; 68: 725–731.

Bessen

Fischetti

: Synthetic peptide vaccine against mucosal colonization by group A streptococci I. Protection against a heterologous M serotype with shared C repeat region epitopes. J Immunol 1990; 145: 1251–1256.

Markowitz

Gerber

Kaplan

: Treatment of streptococcal pharyngotonsillitis: Reports of penicillin's demise are premature. J Pediatr 1993; 123: 679–685.

Liao

Sindhwani

Rojkind

: Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J Exp Med 1995; 181: 1123–1131.

Cromartie

Craddock

Schwab

: Arthritis in rats after systemic injection of streptococcal cells or cell walls. J Exp Med 1977; 146: 1585–1602.

Eisenberg

Fox

Greenblatt

: Measurement of bacterial cell wall in tissues by solid-phase radioimmunoassay: Correlation of distribution and persistence with experimental arthritis in rats. Infect Immun 1982; 38: 127–135.

10.

Fox

Brown

Anderle

: Arthropathie properties related to the molecular weight of peptidoglycanpolysaccharide polymers of streptococcal cell walls. Infect Immun 1982; 35: 1003–1010.

11.

Schwab

Allen

Anderle

: Relationship of complement to experimental arthritis induced in rats with streptococcal cell walls. Immunology 1982; 46: 83–88.

12.

Wells

Pararajasegaram

Baldwin

: Uveitis and arthritis induced by systemic injection of streptococcal cell walls. Invest Ophthalmol Vis Sci 1986; 27: 921–925.

13.

Leon

Daniels

Toriello

: A cardiac myosin-specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins. Infect Immun 2004; 72: 3410–3417.

14.

Olive

Batzloff

Horvath

: A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies. Infect Immun 2002; 70: 2734–2738.